Targeting lysosomal dysfunction to treat age-related macular degeneration

Project Code

MRCNMH26Br Dick

Project Type

Wet lab

Research Theme

Neuroscience and Mental Health

Project Summary Download

Summary

Age-related macular degeneration (AMD) is the leading cause of blindness in the developed world. Projected to affect 288M by 2040, there are no therapeutic options for the common form of AMD (dry AMD) approved in the UK. Emerging research highlights common disease pathways between AMD and a group of inherited metabolic diseases, lysosomal storage disorders (LSD), with vision loss a common early symptom in many LSDs. This project will draw on knowledge gained from the study of LSDs to investigate key aspects of lysosomal health in AMD models, and explore the potential for repurposing LSD approved therapeutics to treat AMD.

Lead Supervisor

Professor Andrew Dick

Lead Supervisor Email

a.dick@bristol.ac.uk

University Affiliation

Bristol